Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACT: Adjuvant Docetaxel in Early Breast Cancer
NCT00033683Phase 2Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- Feb 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by The Institute of Cancer Research. Status: unknown.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00033683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033683.